Cullinan Therapeutics, Inc. logo CGEM - Cullinan Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 8
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $32.17 DETAILS
HIGH: $38.00
LOW: $28.00
MEDIAN: $30.00
CONSENSUS: $32.17
UPSIDE: 132.44%

Profitability Ratios

Ratio Value
GP Margin 0.0%
EBIT Margin 0.0%
EBITDA Margin 0.0%
Operating Margin 0.0%
Pretax Margin 0.0%
Cont. Ops Margin 0.0%
Net Margin 0.0%
Bottom Line Margin 0.0%

Liquidity Ratios

Ratio Value
Current Ratio 10.25
Quick Ratio 10.25
Solvency Ratio -5.538
Cash Ratio 2.34

Valuation Ratios

Ratio Value
Price/Earnings
-2.78
Hist. avg: 4.3
Peers avg: 17.5
PEG Ratio -0.14
Forward PEG -0.14
Price/Book 1.50
Price/Sales 0.00
Price/FCF -3.48
Price/Op Cash Flow -3.48

Debt Ratios

Ratio Value
Debt/Assets 0.0060
Debt/Equity 0.0066
Debt/Capital 0.0065
Long-Term Debt/Capital 0.0046
Financial Leverage 1.10

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -4.657
Operating Cash Flow/Sales 0.0%
Free Cash Flow/Operating Cash Flow 100.0%

Coverage Ratios

Ratio Value
Debt Service Coverage -309.41
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage -225.32
Operating Cash Flow Coverage -65.51
Capital Expenditure Coverage -3586.73
Dividend + Capital Expenditure Coverage -3586.73

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.00
EPS -3.724
Debt/Share 0.0454
Cash/Share 6.40
Book Value/Share 6.92
Tangible BV/Share 6.92
Equity/Share 6.92
Operating Cash Flow/Share -2.976
Capital Expenditure/Share 0.001
FCF/Share -2.977

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.910
Price/Fair Value 1.50
Debt/Market Cap 0.0044
Effective Tax Rate 0.0%
Enterprise Value Multiple -2.18